0001209191-23-041260.txt : 20230705
0001209191-23-041260.hdr.sgml : 20230705
20230705180143
ACCESSION NUMBER: 0001209191-23-041260
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230705
DATE AS OF CHANGE: 20230705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Szwarcberg Javier B.
CENTRAL INDEX KEY: 0001903669
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39594
FILM NUMBER: 231071106
MAIL ADDRESS:
STREET 1: 2001 JUNIPERO SERRA BOULEVARD, SUITE 640
CITY: DALY CITY
STATE: CA
ZIP: 94014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPRUCE BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001683553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812154263
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BOULEVARD, SUITE 740
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (415) 655-4168
MAIL ADDRESS:
STREET 1: 611 GATEWAY BOULEVARD, SUITE 740
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-30
0
0001683553
SPRUCE BIOSCIENCES, INC.
SPRB
0001903669
Szwarcberg Javier B.
C/O SPRUCE BIOSCIENCES, INC.
611 GATEWAY BOULEVARD, SUITE 740
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-06-30
5
A
0
E
20000
0.9775
A
34705
D
Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
/s/ Samir Gharib, Attorney-in-Fact
2023-07-05